Behavioral changes of Wistar rats with experimentally-induced painful diabetic neuropathy

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 3 B, 1999, Pages 746-752

  D'Almeida, José Artur C ^a   De Castro Costa, Carlos M ^b   Frota, Carina H ^b   Severo, Janaira F ^b   Rocha, Tarciso D S ^b   Nogueira, Trícia F ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE

Author keywords

Chronic pain; Experimental diabetic neuropathy; Long term profile; Morphine; Naloxone; Painful neuropathy; Spontaneous scratching behavior

Indexed keywords

MORPHINE; NALOXONE; STREPTOZOCIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEEDING BEHAVIOR; HYPERALGESIA; MALE; MOTOR PERFORMANCE; NONHUMAN; RAT; SCRATCHING; SLEEP DISORDER; STREPTOZOCIN DIABETES;

EID: 0032822398     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000500004     Document Type: Article

References (21)

1. Rowbotham M. Chronic pain: from theory to practical management. Neurology 1995;45(Suppl 9):S5-S10.
2. De Castro-Costa CM, Sutter P, Gybels J, Hees JV. Adjuvant-induced arthritis in rats; a possible animal model of chronic pain. Pain 1981;10:173-185.
3. De Castro-Costa CM, Gybels J, Kupers R, Hees JV. Scratching behavior in arthritic rats: a sign of chronic pain or itch? Pain 1987;29:123-131.
4. Barbosa VLF. Possível alteração do sistema nociceptivo pela dor crônica animal (uma análise comportamental-farmacológica). Dissertação de Mestrado, Universidade Federal do Ceará Fortaleza, 1990.
5. Kupers RC, Nuytten D, De Castro-Costa CM, Gybels J. A time course analysis of the changes in spontaneous and evoked behavior in a rat model of neuropathic pain. Pain 1992;50:101-111.
6. Moura FEA. Estudo Comportamental-farmacológico de ratos portadores de mononeuropatia ciática compressiva crônica: um modelo animal de dor neuropática. Dissertação de Mestrado, Universidade Federal do Ceará Fortaleza, 1994.
7. Santos TJT. Analgesic effect of baclofen (beta-p-chlorofenil-GABA) in experimental neuropathic pain (abstract). Arq Neuropsiquiatr 1996;54:712-713.
8. Medinaceli L, Freed W, Wyatt RJ. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exper Neurol 1982;77:634-643.
9. Attal N, Jazat F, Kayser V. Further evidences for pain-related behaviours in a model of unilateral peripheral mononeuropathy. Pain 1990;41:235-251.
10. IASP Committee for Research and Ethical Issues. Ethical standards for investigation of experimental pain in animal. Pain 1983;16:109-110.
11. Courteix C, Eschalier A, Lavarenne J. Streptozotocin-induced diabetic rats: behavioral evidence for a model of chronic pain. Pain 1993;53:81-88.
12. Ziegler D, Mayer P, Wiefels K, Gries FA. Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain 1988;34:1-10.
13. Yoon YW, Na HS, Chung JM. Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain 1996;64:27-36.
14. Papir-Kricheli D, Frey J, Laufer R, et al. Behavioral effects of receptor-specific substance P agonists. Pain 1987;31:263-276.
15. Greidanus TBVW, Maigret C. Grooming behavior induced by substance P. Eur Pharmacol 1988;154:217-220.
16. Frenk H, Bossut D, Urea G, Mayer DJ. Is substance P a primary afferent neurotransmitter for nociceptive input? Analysis of pain-related behaviors resulting from intrathecal administration of substance P and 6 excitatory compounds. Brain Res 1988;455:223-231.
17. Beyer C, Banas C, Gonzales-Flores O, Komisaruk BR. Blockage of substance P-induced scratching behavior in rats by the intrathecal administration of inhibitory amino acid agonists. Pharmacol Biochem Behav 1989;34:491-495.
18. Forman LJ, Estilow S, Lewis M, Vasilenko P. Streptozocin diabetes alters immunoreactive β-endorphin levels and pain perception after 8 wk in female rats. Diabetes 1986;35:1309-1313.
19. Simon GS, Dewey WL. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J Pharmacol Exp Therap 1981;218:318-323.
20. Kamei J, Saitoh A, Kasuya Y. Involvement of d1-opioid receptors in the antinociceptive effects of mcxiletine in mice. Neurosci Lett 1995;196:169-172.
21. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995;61:353-364.